Emphysema Trial

Related by string. * emphysema : subcutaneous emphysema . chronic bronchitis emphysema . emphysema chronic bronchitis . asthma bronchitis emphysema . bronchitis emphysema . Emphysema / trialed . trialing . trials . Trials . trial . TRIAL : Phase III clinical trials . Week Premium Trial . Phase III trials . placebo controlled clinical trials . randomized controlled trial . randomized controlled trials * *

Related by context. Frequent words. (Click for all words.) 55 stereotactic body 55 Pervasis 55 Phase Ib clinical 54 Cancer Immunotherapy 54 immuno inflammatory diseases 53 placebo controlled clinical 53 prospective multicenter 53 label dose escalation 52 pertuzumab 52 Mipomersen 52 Pivotal Trial 52 OTCQX RHHBY 52 Tesetaxel 51 randomized controlled clinical 51 InfraReDx 51 photodynamic therapy PDT 51 myeloproliferative disorders 51 multicenter Phase 51 PsychoGenics 51 multi kinase inhibitor 51 multicenter clinical 51 phase IIb clinical 51 P#X# 51 Heart Failure Trial 51 Acute Myocardial Infarction 50 PFO closure 50 Genaera Corporation 50 anticancer compound 50 InnerCool Therapies 50 optical coherence tomography OCT 50 minimally invasive technique 50 Celsion Corporation 50 Clinical Trial Results 50 Phase III randomized 50 immunotherapeutics 50 diabetic macular edema DME 50 MicroDose 50 Glioma 50 Carfilzomib 50 label multicenter 50 BrainScope 50 Phase 2a clinical 50 Pulmonary Arterial Hypertension 50 ZD# [001] 50 Multicenter 50 spinal cord stimulation 50 Cytori Therapeutics NASDAQ CYTX 50 Drug Eluting Stents 50 Atiprimod 50 Optical Coherence Tomography OCT 50 CR# vcMMAE 50 optical coherence tomography 50 molecular biomarkers 49 Biomarker Discovery 49 prospective randomized controlled 49 Lipid Sciences Inc. 49 anticancer agent 49 Ablation Frontiers 49 Anavex Life Sciences 49 EnVivo Pharmaceuticals 49 brain stimulation DBS 49 KineMed 49 Ischemia 49 Dynavax Technologies Corporation 49 Biotherapeutics 49 Progenics Pharmaceuticals 49 multicenter study 49 angiogenesis inhibitor 49 Autoimmunity 49 antifungal agent 49 Phase IIB 49 Promedior 49 phase IIa 49 Azedra 49 BAY #-# 49 Stent System 49 Radiosurgery 49 Aethlon Medical Inc. 49 Positron Emission Tomography PET 49 placebo controlled Phase 49 Sym# 49 Versartis 49 Cardiac Resynchronization Therapy 49 Peripheral Artery Disease 48 hepatitis C HCV 48 vascular disorders 48 therapeutic monoclonal antibodies 48 Aliskiren 48 ANG# 48 FoldRx 48 annual Transcatheter Cardiovascular 48 vorinostat 48 PRECISE 48 exon skipping 48 Rosuvastatin 48 idiopathic pulmonary fibrosis IPF 48 rFVIIIFc 48 Investigational Device Exemption IDE 48 randomized clinical 48 Coronary Stent 48 Argos Therapeutics

Back to home page